Dr. T. Narender Kumar

Speciality:      Medical Oncologist
Experience:   12+ years of experience
Hospital:        KIMS Hospital, Secunderabad, Hyedrabad

Brief about doctor:

• T. Narender Kumar is a Medical Oncologist at KIMS Hospital, Secunderabad, Hyedrabad.
• Having a rich experience of 12 years in the field of Medical Oncologist.
• His areas of interests are Medical Oncology Hemato Oncology Haematology,Cancer Screening (Preventive) Blood Transfusion Lymphatic drainage Stem Cell Transplantation.

• Having Fellowship in Hematology – Los Angeles, California.
• He got many awards because of excellent performance in the field of treatment.
• T. Narender Kumar is an active member of Indian Society of Medical and Paediatric Oncology (ISMPO).

Education & Memberships:

• MBBS – Kakatiya Medical College, Wrangal, 2002
• DNB – General Medicine – Gandhi Medical College, Hyderabad, 2008
• DM – Oncology – Nizam Institute of Medical Sciences, Hyderabad, 2012
• Indian Medical Association (IMA)
• Indian Society of Medical and Paediatric Oncology (ISMPO)
• American Society of Clinical Oncology (ASCO)
• European Society of Medical Oncology (ESMO)
• Indian Society of Hematology and Blood Transfusion

Special areas of interest:

• Medical Oncology
• Hemato Oncology
• Haematology
• Cancer Screening (Preventive)
• Blood Transfusion
• Lymphatic drainage
• Stem Cell Transplantation

List of treatment procedures:

• Chemotherapy
• Acute Lymphocytic Leukemia – ALL in Adults
• Breast Biopsy
• Hairy Cell Leukemia – HCL
• Metastatic Tumors Treatment

• Adrenal Cancer Treatment
• Anal Cancer Treatment
• Bile Duct Cancer Treatment
• Bladder Cancer Treatment
• Breast Cancer-Surgical
• Cancer in Children
• Carcinoma of Unknown Primary (CUP) Treatment
• Castleman Disease Treatment
• Cervical Cancer Treatment
• Endometrial Cancer Treatment
• Esophagus Cancer Treatment
• Ewing Family of Tumors Treatment
• Eye Cancer Treatment
• Gallbladder Cancer Treatment
• Gestational Trophoblastic Disease (GTD) Treatment
• Hodgkin Disease Treatment
• Laryngeal and Hypopharyngeal Cancer Treatment
• Leukemia in Children
• Liver Cancer
• Lung Cancer Treatment
• Non-Small Cell Lung Cancer (NSCLC) Treatment
• Small-cell Carcinoma Treatment
• Lung Carcinoid Tumor Treatment
• Skin Lymphoma Treatment
• Malignant Mesothelioma Treatment
• Nasopharyngeal Cancer Treatment
• Neuroblastoma
• Non-Hodgkin Lymphoma (NHL) Treatment
• Non-Hodgkin Lymphoma In Children
• Oral Cavity and Oropharyngeal Cancer
• Ovarian Cancer Surgery
• Pancreatic Cancer
• Penile Cancer Treatment
• Prostate Cancer-Surgical
• Retinoblastoma (RB) Treatment
• Rhabdomyosarcoma (RMS) Treatment
• Salivary Gland Cancer
• Soft Tissue Sarcoma Treatment
• Skin Cancer
• Skin Cancer – Melanoma
• Stomach Cancer Treatment
• Testicular Cancer Treatment
• Thymoma and Thymic Carcinoma Treatment
• Thyroid Cancer Treatment
• Uterine Sarcoma
• Vaginal Cancer Treatment
• Vulvar Cancer Treatment
• Waldenstrom Macroglobulinemia
• Wilms Tumor (Nephroblastoma)
• Pediatric Bone Marrow Transplant
• Oral Cancer – Surgical
• Breast Cancer
• Leukemia Treatment
• Fallopian Tube Cancer
• Ovarian Germ Cell Tumor
• Ovarian Primary Peritoneal Cancer
• Medullary Carcinoma
• Papillary Thyroid Cancer Treatment
• Ovarian Sex Cord Stromal Tumor
• Invasive Lobular Carcinoma
• Colon Cancer Treatment
• Adenocarcinoma – Glandular Cancer Treatment
• Immunotherapy
• Radiotherapy
• IMRT
• Small Intestine Cancer Treatment
• Bone Marrow Cancer
• Cancer Treatment
• Breast Conservation Surgery – BCS
• Breast Lumpectomy